vs
Canopy Growth Corp（CGC）与MediWound Ltd.（MDWD）财务数据对比。点击上方公司名可切换其他公司
Canopy Growth Corp的季度营收约是MediWound Ltd.的9.5倍（$54.4M vs $5.7M）。Canopy Growth Corp净利率更高（-84.0% vs -233.3%，领先149.3%）。MediWound Ltd.同比增速更快（12.7% vs -0.3%）
Canopy Growth Corp前身为Tweed Marijuana Inc，是一家总部位于加拿大安大略省史密斯福尔斯的大麻企业，在北美大麻行业拥有较高知名度，主要从事大麻相关产品的研发、生产与销售业务。
MediWound Ltd.是一家聚焦烧伤护理、慢性创面治疗及软组织修复领域的生物制药企业，研发、生产及销售创新创面护理产品，主要面向北美、欧洲及亚洲市场的医院、医疗机构及患者提供服务。
CGC vs MDWD — 直观对比
营收规模更大
CGC
是对方的9.5倍
$5.7M
营收增速更快
MDWD
高出13.0%
-0.3%
净利率更高
CGC
高出149.3%
-233.3%
损益表 — Q3 2026 vs Q2 2025
| 指标 | | |
|---|---|---|
| 营收 | $54.4M | $5.7M |
| 净利润 | $-45.7M | $-13.3M |
| 毛利率 | 28.8% | 23.5% |
| 营业利润率 | -35.3% | -100.1% |
| 净利率 | -84.0% | -233.3% |
| 营收同比 | -0.3% | 12.7% |
| 净利润同比 | 48.6% | -111.2% |
| 每股收益（稀释后） | — | $-1.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CGCMDWD
| Q4 25 | $54.4M | — | ||
| Q3 25 | $48.7M | — | ||
| Q2 25 | $52.7M | $5.7M | ||
| Q1 25 | $47.5M | — | ||
| Q4 24 | $54.6M | — | ||
| Q3 24 | $46.0M | — | ||
| Q2 24 | $48.3M | $5.1M | ||
| Q1 24 | $53.1M | — |
净利润CGCMDWD
| Q4 25 | $-45.7M | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-30.3M | $-13.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | $-89.0M | — | ||
| Q3 24 | $-93.7M | — | ||
| Q2 24 | $-92.8M | $-6.3M | ||
| Q1 24 | — | — |
毛利率CGCMDWD
| Q4 25 | 28.8% | — | ||
| Q3 25 | 32.8% | — | ||
| Q2 25 | 25.0% | 23.5% | ||
| Q1 25 | 16.2% | — | ||
| Q4 24 | 32.2% | — | ||
| Q3 24 | 34.7% | — | ||
| Q2 24 | 34.8% | 8.8% | ||
| Q1 24 | 21.3% | — |
营业利润率CGCMDWD
| Q4 25 | -35.3% | — | ||
| Q3 25 | -25.3% | — | ||
| Q2 25 | -31.4% | -100.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | -31.9% | — | ||
| Q3 24 | -72.9% | — | ||
| Q2 24 | -44.0% | -88.6% | ||
| Q1 24 | — | — |
净利率CGCMDWD
| Q4 25 | -84.0% | — | ||
| Q3 25 | -2.5% | — | ||
| Q2 25 | -57.6% | -233.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | -163.0% | — | ||
| Q3 24 | -203.7% | — | ||
| Q2 24 | -192.0% | -124.5% | ||
| Q1 24 | — | — |
每股收益（稀释后）CGCMDWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-1.23 | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-0.68 | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $271.1M | $1.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $553.5M | $20.1M |
| 总资产 | $807.5M | $67.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CGCMDWD
| Q4 25 | $271.1M | — | ||
| Q3 25 | $217.6M | — | ||
| Q2 25 | $104.8M | $1.1M | ||
| Q1 25 | $96.0M | — | ||
| Q4 24 | $130.2M | — | ||
| Q3 24 | $168.8M | — | ||
| Q2 24 | $142.3M | $3.8M | ||
| Q1 24 | $148.5M | — |
股东权益CGCMDWD
| Q4 25 | $553.5M | — | ||
| Q3 25 | $537.3M | — | ||
| Q2 25 | $357.0M | $20.1M | ||
| Q1 25 | $355.7M | — | ||
| Q4 24 | $431.8M | — | ||
| Q3 24 | $372.1M | — | ||
| Q2 24 | $389.0M | $17.9M | ||
| Q1 24 | $365.3M | — |
总资产CGCMDWD
| Q4 25 | $807.5M | — | ||
| Q3 25 | $781.0M | — | ||
| Q2 25 | $660.4M | $67.0M | ||
| Q1 25 | $669.9M | — | ||
| Q4 24 | $849.9M | — | ||
| Q3 24 | $899.6M | — | ||
| Q2 24 | $938.9M | $57.3M | ||
| Q1 24 | $949.2M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CGCMDWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-7.5M | $-5.8M | ||
| Q1 25 | $-121.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-37.8M | $-3.6M | ||
| Q1 24 | $-205.8M | — |
自由现金流CGCMDWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-8.5M | — | ||
| Q1 25 | $-128.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-40.7M | — | ||
| Q1 24 | $-208.3M | — |
自由现金流率CGCMDWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -16.1% | — | ||
| Q1 25 | -271.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -84.1% | — | ||
| Q1 24 | -392.1% | — |
资本支出强度CGCMDWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 16.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 4.7% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CGC
| CA | $45.4M | 84% |
| International Markets Cannabis | $6.2M | 11% |
| Other | $1.5M | 3% |
| Other Geographical Area | $1.2M | 2% |
MDWD
暂无分部数据
